EDC-3

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEDC-3
Drug Alias Nameextracellular drug conjugate-3extracellular drug conjugate-3 (Centrose)EDC-3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionL-type amino acid transporter 1 modulatorsSodium/potassium-transporting ATPase modulators
TargetsL-type amino acid transporter 1Sodium/potassium-transporting ATPase
Therapy Area/IndicationsInflammationDiabetes MellitusNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentrose LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentrose LLC
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes MellitusNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A